LabGenomics Co., Ltd. (KOSDAQ:084650)

LabGenomics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,069	24,510	42,324	98,511	70,528	37,834
Short-Term Investments	56,787	66,354	73,066	38,461	28,470	15,351
Cash & Short-Term Investments	72,856	90,864	115,391	136,971	98,998	53,185
Cash Growth	-31.24%	-21.25%	-15.76%	38.36%	86.14%	273.97%
Accounts Receivable	33,301	37,765	37,123	35,317	68,417	31,550
Other Receivables	1,219	1,437	94.01	214.65	76.3	102.91
Receivables	34,803	39,518	37,230	35,531	68,493	31,652
Inventory	4,171	3,741	2,269	1,743	2,693	2,464
Prepaid Expenses	1,138	962.08	747.77	109.27	77.14	119.77
Other Current Assets	508.43	482.33	4,741	127.6	668.62	104.23
Total Current Assets	113,476	135,567	160,378	174,483	170,931	87,526
Property, Plant & Equipment	52,139	57,359	54,957	54,885	19,698	7,987
Long-Term Investments	14,849	15,656	20,253	16,354	10,700	7,392
Goodwill	53,820	58,327	54,890	0	0	-
Other Intangible Assets	20,633	24,369	21,124	871.46	266.27	231.83
Long-Term Accounts Receivable	-	-	-	-0	0	0
Long-Term Deferred Tax Assets	7,376	2,650	-	1,994	1,101	2,335
Long-Term Deferred Charges	-	-	43.74	143.71	473.28	1,421
Other Long-Term Assets	2,597	1,342	1,761	1,922	1,118	2,472
Total Assets	265,176	295,662	313,457	250,653	204,287	109,364
Accounts Payable	10,429	9,646	9,286	6,564	11,387	8,089
Accrued Expenses	2,525	3,613	6,327	2,148	501.44	462.51
Short-Term Debt	30,493	-	-	-	-	2,500
Current Portion of Long-Term Debt	3,000	44,711	29,252	-	-	100
Current Portion of Leases	1,642	2,621	1,957	1,033	919.83	1,196
Current Income Taxes Payable	2	2.17	91.45	5,434	21,646	9,757
Current Unearned Revenue	34.54	50.32	10.47	-	-	-
Other Current Liabilities	12,588	15,671	18,132	4,716	6,230	2,912
Total Current Liabilities	60,713	76,315	65,055	19,896	40,683	25,016
Long-Term Debt	13,000	-	16,000	19,200	3,200	-
Long-Term Leases	892.35	2,869	2,786	995.45	1,201	1,696
Long-Term Deferred Tax Liabilities	-	-	1,474	-	-	-
Other Long-Term Liabilities	1,175	163.36	-0	0	-0	0
Total Liabilities	75,781	79,348	85,314	40,142	45,865	27,723
Common Stock	37,180	37,180	37,180	17,056	5,725	5,725
Additional Paid-In Capital	19,384	19,384	19,314	16,687	29,097	29,110
Retained Earnings	126,591	146,617	170,243	174,863	129,740	46,880
Treasury Stock	-	-	-	-	-7,933	-1,390
Comprehensive Income & Other	6,240	13,134	1,058	725.12	1,087	1,219
Total Common Equity	189,395	216,314	227,795	209,331	157,715	81,543
Minority Interest	-	-	347.27	1,179	706.08	97.09
Shareholders' Equity	189,395	216,314	228,143	210,510	158,421	81,640
Total Liabilities & Equity	265,176	295,662	313,457	250,653	204,287	109,364
Total Debt	49,027	50,202	49,994	21,228	5,321	5,492
Net Cash (Debt)	23,829	40,662	65,396	115,743	93,678	47,694
Net Cash Growth	-59.40%	-37.82%	-43.50%	23.55%	96.42%	1590.23%
Net Cash Per Share	320.97	547.71	880.88	1709.14	1386.06	724.11
Filing Date Shares Outstanding	74.24	74.24	74.24	67.98	66.65	67.93
Total Common Shares Outstanding	74.24	74.24	74.24	67.98	66.65	67.93
Working Capital	52,763	59,252	95,323	154,587	130,248	62,510
Book Value Per Share	2551.12	2913.71	3068.37	3079.15	2366.39	1200.35
Tangible Book Value	114,942	133,618	151,781	208,459	157,449	81,311
Tangible Book Value Per Share	1548.25	1799.81	2044.47	3066.34	2362.40	1196.94
Land	21,016	21,016	21,016	21,286	3,061	1,275
Buildings	24,003	24,003	24,003	26,420	6,600	2,437
Machinery	4,501	5,029	4,527	3,918	2,685	2,438
Construction In Progress	-	-	16.5	414.2	5,307	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.